According to our data, the level of FLOT1 was elevated compared to D-MSCs in AML-MSCs’ proteome at the onset (Log2FC = 1.38, p = 0.004) and in remission (Log2FC = 1.59, p = 0.027). Here, FLOT1 is linked to acute myeloid leukemia.